Fig. 2From: Pharm-MD; an open-label, randomized controlled, phase II study to evaluate the efficacy of a pharmacist-managed diabetes clinic in high-risk diabetes patients – study protocol for a randomized controlled trialMeasurement of study outcomes, and assessment timelinesBack to article page